CONMED Corporation Financials

Market Capitalization $1.25 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	19.77
Forward PE	9.08
Price to Sales TTM	$0.93
Price to Book MRQ	$1.24
Enterprise to Revenue	1.54
Enterprise to EBITDA	9.17

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-09-30
Profit Margin	4.76%
Operating Margin	10.84%
Return on Assets TTM	4.15%
Return on Equity TTM	6.60%

Income Statement

Revenue TTM	$1,347,469,952
Revenue per Share TTM	$43.46
Quarterly Revenue Growth	6.70%
Gross Profit TTM	$761,134,016
EBITDA	$191,516,000
Net Income to Common TTM	$64,071,000
Diluted EPS TTM	$2.05
Quarterly Earnings Growth YoY	-94.20%

Balance Sheet

Total Cash MRQ	$38,929,000
Total Cash per Share MRQ	$1.26
Total Debt MRQ	$
Total Debt to Equity MRQ	84.68
Current Ratio MRQ	2.10
Book Value per Share MRQ	$32.57

Cash Flow

Operating Cash Flow TTM	$167,692,000
Levered Free Cash Flow TTM	$177,268,368

CNMD Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	30,955,051
Float Shares	30,681,810
Avg 10 Volume	438,761
Avg 30 Volume	None
Shares Short	2,362,201
Short Ratio	3.73
Short % of Shares	10.41%
% Held by Insiders	0.59%
% Held by Institutions	114.24%

Stock Price Summary

Beta	0.98
Fifty Two Week Low	$38.32
Fifty Two Week High	$74.70
Fifty Two Week Change	-69.25%
Day 50 MA	$42.90
Day 200 MA	$50.51

Dividends and Splits

Forward Annual Dividend Rate	$0.80
Forward Annual Dividend Yield	1.97%
Trailing Annual Dividend Rate	$0.80
Trailing Annual Dividend Yield	1.97%
Payout Ratio	39.02%
Dividend Date	2025-10-03
Ex Dividend Date	2025-09-15
Last Split Factor
Last Split Date	2001-09-10